The Medicare Part D doughnut hole: effect on pharmacy utilization.

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Geriatric Medicine

Background:

• Medicare Part D, established by the Medicare Prescription Drug Improvement and Modernization Act of 2003, provides prescription drug coverage.
• The standard Medicare Part D benefit includes a coverage gap, often called the "doughnut hole."

Purpose of the Study:

• To evaluate the impact of the Medicare Part D coverage gap on prescription drug utilization and expenditures.
• To assess changes in medication adherence and out-of-pocket costs for beneficiaries experiencing the coverage gap.

Main Methods:

• A large-scale study involving 90,615 subjects comparing beneficiaries within and outside the coverage gap.
• Utilized difference-in-differences models to analyze changes in medication days of therapy, total costs, and out-of-pocket expenses pre- and post-coverage gap.
• Controlled for demographic and health status differences between study and control groups.

Main Results:

• Beneficiaries in the coverage gap experienced an 18.75% decrease in days of therapy and an 88.94% increase in out-of-pocket costs.
• Total prescription costs decreased by 28.02% for those in the gap, while out-of-pocket expenses rose significantly.
• In contrast, the control group showed a slight increase in days of therapy and total costs, with a decrease in out-of-pocket expenses.

Conclusions:

• The Medicare Part D coverage gap significantly reduces medication utilization among beneficiaries.
• The gap leads to a substantial increase in out-of-pocket prescription drug costs for Medicare beneficiaries.
• Reduced medication use due to the coverage gap raises concerns about potential adverse health events for Medicare Part D recipients.